Shijiazhuang Yiling Pharmaceutical Co Ltd Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd asset resilience ratio. Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has an Asset Resilience Ratio of 9.04% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shijiazhuang Yiling Pharmaceutical Co Lt (002603) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Shijiazhuang Yiling Pharmaceutical Co Ltd (2013–2025)
Asset resilience ratio of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2013 to 2025. This chart shows how Shijiazhuang Yiling Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Shijiazhuang Yiling Pharmaceutical Co Lt debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Shijiazhuang Yiling Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Shijiazhuang Yiling Pharmaceutical Co Lt.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.26 Billion | 9.04% |
| Total Liquid Assets | CN¥1.26 Billion | 9.04% |
Asset Resilience Insights
- Limited Liquidity: Shijiazhuang Yiling Pharmaceutical Co Ltd maintains only 9.04% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shijiazhuang Yiling Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shijiazhuang Yiling Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Shijiazhuang Yiling Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2013–2025)
Shijiazhuang Yiling Pharmaceutical Co Ltd asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for Shijiazhuang Yiling Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.59% | CN¥764.42 Million ≈ $111.86 Million |
CN¥13.67 Billion ≈ $2.00 Billion |
+4.38pp |
| 2023-12-31 | 1.21% | CN¥205.97 Million ≈ $30.14 Million |
CN¥16.98 Billion ≈ $2.48 Billion |
-1.96pp |
| 2022-12-31 | 3.17% | CN¥518.38 Million ≈ $75.86 Million |
CN¥16.34 Billion ≈ $2.39 Billion |
+2.74pp |
| 2021-12-31 | 0.43% | CN¥55.27 Million ≈ $8.09 Million |
CN¥12.90 Billion ≈ $1.89 Billion |
-1.46pp |
| 2020-12-31 | 1.89% | CN¥216.97 Million ≈ $31.75 Million |
CN¥11.51 Billion ≈ $1.68 Billion |
-1.34pp |
| 2019-12-31 | 3.23% | CN¥292.73 Million ≈ $42.84 Million |
CN¥9.07 Billion ≈ $1.33 Billion |
-5.03pp |
| 2018-12-31 | 8.26% | CN¥706.72 Million ≈ $103.42 Million |
CN¥8.56 Billion ≈ $1.25 Billion |
-2.69pp |
| 2017-12-31 | 10.95% | CN¥863.39 Million ≈ $126.34 Million |
CN¥7.89 Billion ≈ $1.15 Billion |
+9.37pp |
| 2016-12-31 | 1.58% | CN¥98.94 Million ≈ $14.48 Million |
CN¥6.26 Billion ≈ $915.73 Million |
+1.00pp |
| 2015-12-31 | 0.58% | CN¥33.37 Million ≈ $4.88 Million |
CN¥5.71 Billion ≈ $835.11 Million |
-7.33pp |
| 2014-12-31 | 7.92% | CN¥402.81 Million ≈ $58.94 Million |
CN¥5.09 Billion ≈ $744.52 Million |
-2.39pp |
| 2013-12-31 | 10.30% | CN¥480.00 Million ≈ $70.24 Million |
CN¥4.66 Billion ≈ $681.62 Million |
-- |
About Shijiazhuang Yiling Pharmaceutical Co Ltd
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine in China and internationally. It offers dietary supplements, and healthy food and drinks; patent TCM products for respiratory health, cardiovascular disease, diabetes, mellitus, oncology, urologic disease, sleep-improving, and anti-aging; disinfection and pers… Read more